Username
Password
Home
Forgotten Password?
Register Now
Site Map
Advertising
THE DEFINITIVE ARTICLE SEARCH FOR THE GLOBAL PHARMACEUTICALS MARKET
Search:
Advanced Search
This channel:
Outsourced Services
>
Clinical-Trials-Phase-I-to-IV
>
Clinical Trials Phase I to IV
Most popular article in
Clinical Trials Phase I to IV
Xamiol (R) - LEO Pharma's new drug for the treatment of scalp psoriasis - is approved in Europe
More in detail
Company
:
LEO Pharma
Date Published
:
19/08/2008
Articles in
Clinical Trials Phase I to IV:
Select to view sub-categories of this category
View All
Clinical Research (Field)
Clinical Trials Phase I to IV
Data management
Drug Metabolism
In-patient clinical research
Patient safety monitoring
Pharmacodynamics
Pharmacoeconomics
Pharmacogenetics
Pharmacokinetics
Project management
Statistical analysis
Subject
Contributor
Date Published
Tibotec begins enrollment in Europe for Phase III trial of telaprevir in HCV patients who failed prior treatment
Tibotec Therapeutics
20/11/2008
Second Sight Expands International Clinical Trial For Argus II Retinal Implant
Second Sight® Medical Products, Inc
19/11/2008
Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission Of Important Imvamune(R) Data To The U.S. Health Authorities
Bavarian Nordic A/S
19/11/2008
Ginkgo Biloba for prevention of dementia - statement of Dr. Willmar Schwabe Pharmaceutical’s about the ginkgo evaluation of memory (gem) study in the journal of the American Medical Association: gem study leaves questions unanswered
Dr. Willmar Schwabe Pharmaceuticals
19/11/2008
Shire Plc: Investor Seminar
Shire PLC
18/11/2008
IDM Pharma Receives Recommendation For Approval Of Mifamurtide (Mepact(R), L-MTP-PE) For The Treatment Of Patients With Non-Metastatic, Resectable Osteosarcoma In Europe From The Committee For Medicinal Products For Human Use (CHMP)
IDM Pharma, Inc.
18/11/2008
Lilly Selects Icon To Manage Its Clinical Data Management Businessoutside The US
ICON plc
18/11/2008
First Pivotal Trials Begin For Boehringer Ingelheim's Novel Triple Angiokinase Inhibitor Vargatef(TM) (BIBF 1120)
Boehringer Ingelheim
17/11/2008
BIOTRONIK announces positive clinical trial results at American Heart Association Scientific Sessions
BIOTRONIK GmbH & Co. KG
14/11/2008
OSLO and Toulouse Cancer Clusters join forces to drive European cancer research forward
Oslo Cancer Cluster
13/11/2008
The forgotten cancer - European patient group formed
Sarcoma UK Ltd
13/11/2008
Delphi Genetics and Eurogentec biologics collaborate for antibiotic resistance-gene free GMP manufacturing
Delphi Genetics SA
13/11/2008
Delphi Genetics and Eurogentec biologics collaborate for antibiotic resistance-gene free GMP manufacturing
Eurogentec
13/11/2008
ZaBeCor's Investigational New Drug Application Approved by the FDA
ZaBeCor Pharmaceutical
12/11/2008
Codex agrees to consider ALL evidence for scientific basis of health claims
International Alliance of Dietary/Food Supplement Associations (IADSA)
12/11/2008
Icon Opens Full Service Central Laboratory In India
ICON plc
12/11/2008
Recordaf Registry Will Provide First Global Insight Into Real Life Management Of Atrial Fibrillation - A Major Cause Of Cardiovascular Death And Hospitalization
Sanofi-aventis
12/11/2008
CPC Launches New Web Site Highlighting Medical, Research And Technical Panel, Medclose(TM) VCS Animated Video
CPC of America, Inc
11/11/2008
Marillion Pharmaceuticals And Bracco Imaging S.P.A. Announce License Agreement To Develop And Commercialize Novel Cancer Treatment
Marillion Pharmaceuticals, Inc.
11/11/2008
Raptor Pharmaceuticals Corp. Announces Positive Phase IIA Clinical Study Results For Convivia(TM) Program
Raptor Pharmaceuticals
11/11/2008
First
Previous
1 to 20 of 2141
Next
Last
© CMP information Ltd 2007
Terms and Conditions
Privacy Policy
